Search images on Google      Product Monograph

Active Ingredients:

• fibrinogen (human), 1000 MG/VIAL

DIN: 02393352

Dosage Form(s): POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: 900-1300 MG FIBRINOGEN /VIAL (20MG/ML AFTER REC.). SINGLE-USE VIALS

Schedule: Schedule D

Company: CSL BEHRING CANADA INC

ATC:

• B02 - ANTIHEMORRHAGICS (ATC, WHO, Wiki)
• B02B - VITAMIN K AND OTHER HEMOSTATICS (ATC, WHO)
• B02BB - Fibrinogen (ATC, WHO)
• B02BB01 - FIBRINOGEN, HUMAN (WHO)

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 50ML

 

External Links for Riastap:

Search on Google

• Riastap side effects
• Riastap dosage
• fibrinogen side effects
• fibrinogen dosage